Drareg
Member
- Joined
- Feb 18, 2016
- Messages
- 4,772
I reposting this here as a separate thread. It’s a great article and worth your time.
Midazolam was used in Canada and the UK to treat elderly patients and speed up their death, I’m sure it was the same elsewhere, the evidence is coming from said countries first.
MSM is starting to cover this scandal albeit in the usual whitewashed manner, this website covers more of the issue.
Basically the excess death argument the covid cultists are making is from Midazolam and intubation, this line of treatment was recommended from the top, they abused the procedure of intubation to give themselves an out if questioned.
The use of Midazolam correlates with the spike in covid deaths.
Pneumonia is not a new condition that has appeared due to Covid-19. In 2019 alone, the year prior to the alleged emergence of Covid-19, 272,000 people were admitted to hospital with pneumonia. According to the British Lung Foundation in 2012, 345 people per every 100,000 had one or more episodes of pneumonia. This equates to around 225,000 people suffering pneumoni at least once.
The British Lung Foundation also show us that the majority of cases of pneumonia occur in those who are aged 81 and over. For instance in 2012 1,838 people in every 100,000 people over the age of 81 developed pneumonia, this equates to around 60,000 people over the age of 81 in today’s numbers based on there being around 3.2 million people over the age of 80 in the UK.
So what we’re seeing here is that is a negligible amount of “Covid” deaths in anyone under the age of 60. But we’re really not seeing very many “Covid” deaths in anybody aged between 60 and 80. What we are seeing is a much higher amount of “Covid” deaths in people aged over 85. But what’s so strange about that?
Well nothing when we consider the average life expectancy in the UK is 81 years of age. Plus the fact this is also in line with what we have seen in cases / deaths due to pneumonia in previous years. Don’t forget serious illness in Covid-19 presents pneumonia and accompanying respiratory insufficiency.
Which begs the question of why the entire nation has had to stay at home, social distance, wear a mask, wash their hands, and live under dictatorial tyranny for fifteen months because people who have lived longer than the average life expectancy in the UK have died or are dying? Dying of pneumonia from which we see tens of thousands of deaths every year.
We cannot deny that 2020 did see excess deaths, and you would believe this is due to the hospitals being overwhelmed? Except they weren’t.
Why did so many people die in care homes when hospitals were far from overwhelmed? Surely if they have developed serious complications due to Covid-19 they would require urgent medical attention and hospital treatment?
Because don’t forget we’re told that serious illness in Covid-19 presents pneumonia and accompanying respiratory insufficiency. Therefore typical symptoms include breathlessness, cough, weakness and fever. We’re also told that people who suffer deteriorating respiratory failure and who do not receive intensive care, develop acute respiratory distress syndrome with severe breathlessness.
Why were these people in care homes and not in hospital?
They were in care homes because Matt Hancock gave the order to put them there…
But Matt Hancock’s abandonment of the elderly and vulnerable didn’t end there. Whilst the NHS was busy discharging patients who required medical treatment into care homes under his directive, Matt Hancock and the Department of Health were busy trying to source them all a certain drug known as midazolam.
Midazolam is a commonly used drug in palliative care and is considered one of the four essential drugs needed for the promotion of quality care in dying patients in the United Kingdom. Think of it as diazepam on steroids.
Midazolam is also a drug that has been used in executions by lethal injection in the USA, combined with two other drugs. Midazolam acts as a sedative to make the prisoner unconscious. The other drugs then stop the lungs and heart working. However it has been the source of controversy as several prisoners took a long while to die and appeared to be in pain when midazolam was used.
Midazolam can also cause serious or life-threatening breathing problems such as shallow, slowed, or temporarily stopped breathing that may lead to permanent brain injury or death.
UK regulators state that you should only receive midazolam in a hospital or doctor’s office that has the equipment that is needed to monitor your heart and lungs and to provide life-saving medical treatment quickly if your breathing slows or stops.
What are some of the most important points you should take from this?
The above exchange took place in a parliamentary committee meeting on the 17th April 2020 between Matt Hancock and Dr Evans, who is a fellow Conservative MP.
The following is an extract from an article which confirms the United Kingdom purchased two years worth of Midazolam in March 2020 and were looking to purchase much more –
Supplies of the sedative midazolam have been diverted from France as a “precaution” to mitigate potential shortages in the NHS caused by COVID-19, the Department of Health and Social Care (DHSC) has told The Pharmaceutical Journal.
A spokesperson from Accord Healthcare, one of five manufacturers of the drug, told The Pharmaceutical Journal that it had to gain regulatory approval to sell French-labelled supplies of midazolam injection to the NHS, after having already sold two years’ worth of stock to UK wholesalers “at the request of the NHS” in March 2020.
The DHSC said the request for extra stock was part of “national efforts to respond to the coronavirus outbreak”, which included precautions “to reduce the likelihood of future shortages”.
Why on earth would the United Kingdom need to purchase two years worth of Midazolam, a drug associated with respiratory suppression and respiratory arrest, to treat a disease that causes respiratory suppression and respiratory arrest?
This NHS document states that midazolam should be used for sedation prior to the patient requiring mechanical ventilation, something we know has been required in hospitals for people who have developed severe pneumonia, of which we are told is due to Covid-19. However it also states that midazolam should only be used if 1st line and 2nd line drugs do not provide adequate sedation, but does include the caveat that midazolam alone can be added to 1st line drugs to reduce Propofol infusion rates. Source
Can you see the contradictions here? A policy that has been in place prior to the alleged emergence of Covid-19 clearly states that midazolam can be used for sedation, however dosage should be reduced to 0.5mg in the elderly or unwell due to possible side effects which include cardiorespiratory depression, and extreme caution should be used in administering midazolam to patients suffering respiratory disease.
However a policy created for treating patients allegedly suffering anxiety due to Covid-19, which we’re told is a respiratory disease, clearly states to treat said patient with a starting dose of 2.5mg of Midazolam, or 1.25mg if the patient is “particularly frail”, but to bump this up to 5 – 10mg if the patient is “extremely distressed”. Even the starting dose for the particularly frail is 0.25mg higher than the maximum recommended to administer to the elderly or unwell in sedation guidelines.
According to official data in April 2019 up to 21,977 prescriptions for Midazolam were issued, containing 171,952 items, the vast majority being Midazolam Hydrochloride. However in April 2020 45,033 prescriptions for Midazolam were issued, containing 333,229 items, the vast majority being Midazolam Hydrochloride. That is a 104.91% increase in the number of prescriptions issued for Midazolam and a 93.85% increase in the number of items they contained. But these weren’t issued in hospitals, they were issued by GP practices which can only mean one thing, they were issued for end of life care.
Can you spot the difference? We couldn’t either because there isn’t one.
The spikes in production of Midazolam solution match the spikes of alleged Covid deaths within 28 days of a positive test.
April 2020 – huge surge in Midazolam prescriptions out of hospital and huge surge in production of Midazolam solution.
April 2020 – huge surge in alleged Covid deaths.
January 2021 – huge surge in production of Midazolam solution.
January 2021 – huge surge in alleged Covid deaths.
Hospitals beds in April 2020 30% were down compared to the previous year.
A&E attendance was 57% down in April 2020 compared to the previous year.
Care home deaths were 205% up in April 2020 compared to April 2019.
The vast majority of alleged Covid deaths are people over the age of 85.
Can you not see a strong correlation here between the over prescribing of Midazolam and the seemingly premature ending of life, with the associated deaths being put down as Covid-19?
Did you really believe there’s a virus so clever that it knows to kill people who are disabled? Just look at the ONS statistics. Three in every five alleged Covid-19 deaths occurred in those who suffered learning difficulties and disabilities (see here).
Midazolam was used in Canada and the UK to treat elderly patients and speed up their death, I’m sure it was the same elsewhere, the evidence is coming from said countries first.
MSM is starting to cover this scandal albeit in the usual whitewashed manner, this website covers more of the issue.
Basically the excess death argument the covid cultists are making is from Midazolam and intubation, this line of treatment was recommended from the top, they abused the procedure of intubation to give themselves an out if questioned.
The use of Midazolam correlates with the spike in covid deaths.
Midazolam was used to prematurely end the lives of thousands who you were told had died of Covid-19 and we can prove it; here’s the evidence…
In March 2020 the British people were told that they must “stay at home” in order to “protect the NHS” and “save lives”. They were also told that the authorities needed just “three weeks to flatten…
dailyexpose.co.uk
Pneumonia is not a new condition that has appeared due to Covid-19. In 2019 alone, the year prior to the alleged emergence of Covid-19, 272,000 people were admitted to hospital with pneumonia. According to the British Lung Foundation in 2012, 345 people per every 100,000 had one or more episodes of pneumonia. This equates to around 225,000 people suffering pneumoni at least once.
Midazolam was used to prematurely end the lives of thousands who you were told had died of Covid-19 and we can prove it; here’s the evidence…
In March 2020 the British people were told that they must “stay at home” in order to “protect the NHS” and “save lives”. They were also told that the authorities needed just “three weeks to flatten…
dailyexpose.co.uk
The British Lung Foundation also show us that the majority of cases of pneumonia occur in those who are aged 81 and over. For instance in 2012 1,838 people in every 100,000 people over the age of 81 developed pneumonia, this equates to around 60,000 people over the age of 81 in today’s numbers based on there being around 3.2 million people over the age of 80 in the UK.
So what we’re seeing here is that is a negligible amount of “Covid” deaths in anyone under the age of 60. But we’re really not seeing very many “Covid” deaths in anybody aged between 60 and 80. What we are seeing is a much higher amount of “Covid” deaths in people aged over 85. But what’s so strange about that?
Well nothing when we consider the average life expectancy in the UK is 81 years of age. Plus the fact this is also in line with what we have seen in cases / deaths due to pneumonia in previous years. Don’t forget serious illness in Covid-19 presents pneumonia and accompanying respiratory insufficiency.
Which begs the question of why the entire nation has had to stay at home, social distance, wear a mask, wash their hands, and live under dictatorial tyranny for fifteen months because people who have lived longer than the average life expectancy in the UK have died or are dying? Dying of pneumonia from which we see tens of thousands of deaths every year.
We cannot deny that 2020 did see excess deaths, and you would believe this is due to the hospitals being overwhelmed? Except they weren’t.
Why did so many people die in care homes when hospitals were far from overwhelmed? Surely if they have developed serious complications due to Covid-19 they would require urgent medical attention and hospital treatment?
Because don’t forget we’re told that serious illness in Covid-19 presents pneumonia and accompanying respiratory insufficiency. Therefore typical symptoms include breathlessness, cough, weakness and fever. We’re also told that people who suffer deteriorating respiratory failure and who do not receive intensive care, develop acute respiratory distress syndrome with severe breathlessness.
Why were these people in care homes and not in hospital?
They were in care homes because Matt Hancock gave the order to put them there…
But Matt Hancock’s abandonment of the elderly and vulnerable didn’t end there. Whilst the NHS was busy discharging patients who required medical treatment into care homes under his directive, Matt Hancock and the Department of Health were busy trying to source them all a certain drug known as midazolam.
Midazolam is a commonly used drug in palliative care and is considered one of the four essential drugs needed for the promotion of quality care in dying patients in the United Kingdom. Think of it as diazepam on steroids.
Midazolam is also a drug that has been used in executions by lethal injection in the USA, combined with two other drugs. Midazolam acts as a sedative to make the prisoner unconscious. The other drugs then stop the lungs and heart working. However it has been the source of controversy as several prisoners took a long while to die and appeared to be in pain when midazolam was used.
Midazolam can also cause serious or life-threatening breathing problems such as shallow, slowed, or temporarily stopped breathing that may lead to permanent brain injury or death.
UK regulators state that you should only receive midazolam in a hospital or doctor’s office that has the equipment that is needed to monitor your heart and lungs and to provide life-saving medical treatment quickly if your breathing slows or stops.
What are some of the most important points you should take from this?
- Midazolam induces significant depression of respiration
- UK regulators insist midazolam should only be administered in a hospital or doctor’s office under the supervision of a doctor or nurse to monitor the breathing of the patient in order to provide life saving treatment to the patient if breathing slows or stops.
- Midazolam should be used with extreme caution in elderly patients
The above exchange took place in a parliamentary committee meeting on the 17th April 2020 between Matt Hancock and Dr Evans, who is a fellow Conservative MP.
The following is an extract from an article which confirms the United Kingdom purchased two years worth of Midazolam in March 2020 and were looking to purchase much more –
Supplies of the sedative midazolam have been diverted from France as a “precaution” to mitigate potential shortages in the NHS caused by COVID-19, the Department of Health and Social Care (DHSC) has told The Pharmaceutical Journal.
A spokesperson from Accord Healthcare, one of five manufacturers of the drug, told The Pharmaceutical Journal that it had to gain regulatory approval to sell French-labelled supplies of midazolam injection to the NHS, after having already sold two years’ worth of stock to UK wholesalers “at the request of the NHS” in March 2020.
The DHSC said the request for extra stock was part of “national efforts to respond to the coronavirus outbreak”, which included precautions “to reduce the likelihood of future shortages”.
Why on earth would the United Kingdom need to purchase two years worth of Midazolam, a drug associated with respiratory suppression and respiratory arrest, to treat a disease that causes respiratory suppression and respiratory arrest?
This NHS document states that midazolam should be used for sedation prior to the patient requiring mechanical ventilation, something we know has been required in hospitals for people who have developed severe pneumonia, of which we are told is due to Covid-19. However it also states that midazolam should only be used if 1st line and 2nd line drugs do not provide adequate sedation, but does include the caveat that midazolam alone can be added to 1st line drugs to reduce Propofol infusion rates. Source
Can you see the contradictions here? A policy that has been in place prior to the alleged emergence of Covid-19 clearly states that midazolam can be used for sedation, however dosage should be reduced to 0.5mg in the elderly or unwell due to possible side effects which include cardiorespiratory depression, and extreme caution should be used in administering midazolam to patients suffering respiratory disease.
However a policy created for treating patients allegedly suffering anxiety due to Covid-19, which we’re told is a respiratory disease, clearly states to treat said patient with a starting dose of 2.5mg of Midazolam, or 1.25mg if the patient is “particularly frail”, but to bump this up to 5 – 10mg if the patient is “extremely distressed”. Even the starting dose for the particularly frail is 0.25mg higher than the maximum recommended to administer to the elderly or unwell in sedation guidelines.
According to official data in April 2019 up to 21,977 prescriptions for Midazolam were issued, containing 171,952 items, the vast majority being Midazolam Hydrochloride. However in April 2020 45,033 prescriptions for Midazolam were issued, containing 333,229 items, the vast majority being Midazolam Hydrochloride. That is a 104.91% increase in the number of prescriptions issued for Midazolam and a 93.85% increase in the number of items they contained. But these weren’t issued in hospitals, they were issued by GP practices which can only mean one thing, they were issued for end of life care.
Can you spot the difference? We couldn’t either because there isn’t one.
The spikes in production of Midazolam solution match the spikes of alleged Covid deaths within 28 days of a positive test.
April 2020 – huge surge in Midazolam prescriptions out of hospital and huge surge in production of Midazolam solution.
April 2020 – huge surge in alleged Covid deaths.
January 2021 – huge surge in production of Midazolam solution.
January 2021 – huge surge in alleged Covid deaths.
Hospitals beds in April 2020 30% were down compared to the previous year.
A&E attendance was 57% down in April 2020 compared to the previous year.
Care home deaths were 205% up in April 2020 compared to April 2019.
The vast majority of alleged Covid deaths are people over the age of 85.
Can you not see a strong correlation here between the over prescribing of Midazolam and the seemingly premature ending of life, with the associated deaths being put down as Covid-19?
Did you really believe there’s a virus so clever that it knows to kill people who are disabled? Just look at the ONS statistics. Three in every five alleged Covid-19 deaths occurred in those who suffered learning difficulties and disabilities (see here).
